跳至主導覽 跳至搜尋 跳過主要內容

Role of dysfunctional adipocytes in cholesterol-induced nonobese metabolic syndrome

  • Chang Gung University
  • Chang Gung Memorial Hospital
  • National Defense Medical University
  • Far Eastern Memorial Hospital

研究成果: 期刊稿件文章同行評審

10 引文 斯高帕斯(Scopus)

摘要

Many studies have reported the causes of obese metabolic syndrome (MS); however, the causes of nonobese MS (NMS) remain unknown. In this study, we demonstrated that inflamed dysfunctional adipose tissue plays a crucial role in cholesterol-induced NMS. Control (C), high cholesterol (HC) and HC with 10% fructose in drinking water (HCF) diets were fed to Sprague–Dawley rats for 12 weeks. After 12 weeks, the body weights of the C- and HC-fed rats were comparable, but the weights of the HCF-fed rats were relatively low. Cholesterol caused metabolic problems such as high blood pressure, hypercholesterolemia and hypoinsulinemia. The HCF-fed rats exhibited whole-body insulin resistance with low circulating high-density lipoprotein levels. Increases in the tumor necrosis factor α level in the plasma, the number of CD68+ macrophages and the free nuclear factor-κB level in gonadal white adipose tissue (gWAT) resulted in local inflammation, which appeared as inflamed dysfunctional gWAT. Reduced superoxide dismutases (SODs) deteriorate natural antioxidant defense systems and induce reactive oxygen species in gWAT. Dysregulation of plasma levels of catecholamine, adipokines (leptin and adiponectin), hormone-sensitive lipase and perilipin in cholesterol-induced inflamed adipose tissue contributed to increased lipolysis and increased circulating nonesterified fatty acids. Cholesterol activated inflammation, lipolysis and cell death in 3T3-L1 adipocytes. Moreover, Chol-3T3-CM reduced the population of M2-type Raw264.7 macrophages, indicating that the macrophage polarization is mediated by cholesterol. Together, our findings indicate that inflamed dysfunctional adipocytes are critical in NMS, supporting the development of anti-inflammatory agents as potential therapeutic drugs for treating NMS.

原文英語
頁(從 - 到)309-323
頁數15
期刊Journal of Molecular Endocrinology
60
發行號4
DOIs
出版狀態已出版 - 05 2018

文獻附註

Publisher Copyright:
© 2018 Society for Endocrinology Published by Bioscientifica Ltd.

UN SDG

此研究成果有助於以下永續發展目標

  1. SDG3 健康與福祉
    SDG3 健康與福祉

指紋

深入研究「Role of dysfunctional adipocytes in cholesterol-induced nonobese metabolic syndrome」主題。共同形成了獨特的指紋。

引用此